Virtu KCG Holdings’s iBio IBIO Stock Holding History

Virtu KCG Holdings’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$7K	Sell	4 -15	-79%	-$29.4K	﹤0.01%	2794
2017 Q1	$40K	Buy	+19	New	+$39.5K	﹤0.01%	2881
2016 Q4	–	Sell	-2	Closed	-$6K	–	3576
2016 Q3	$6K	Buy	+2	New	+$6.27K	﹤0.01%	2995
2016 Q1	–	Sell	-5	Closed	-$15K	–	3192
2015 Q4	$15K	Sell	5 -7	-58%	-$22.3K	﹤0.01%	3334
2015 Q3	$42K	Buy	+12	New	+$44.5K	﹤0.01%	3030
2015 Q2	–	Sell	-6	Closed	-$23K	–	3507
2015 Q1	$23K	Sell	6 -4	-40%	-$13.6K	﹤0.01%	2937
2014 Q4	$33K	Sell	10 -10	-50%	-$53.4K	﹤0.01%	3520
2014 Q3	$60K	Buy	+20	New	+$48.8K	﹤0.01%	3313
2014 Q2	–	Sell	-14	Closed	-$36K	–	3828
2014 Q1	$36K	Buy	14 +11	+367%	+$29.4K	﹤0.01%	3378
2013 Q4	$5K	Sell	3 -5	-63%	-$9.11K	﹤0.01%	3749
2013 Q3	$18K	Buy	+8	New	+$19.1K	﹤0.01%	3625

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACP

Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu KCG Holdings's IBIO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its iBio (IBIO) stake by 79% in Q2 2017, selling an estimated $29.4K and leaving 4 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Virtu KCG Holdings first reported a position in IBIO in Q3 2013 and has held it in 11 quarters since. The position peaked at $60K in Q3 2014. 17 funds tracked by Wall St. Rank hold IBIO as of Q2 2017.

Virtu KCG Holdings held 4 shares of iBio worth $7K as of Q2 2017.
Virtu KCG Holdings sold 15 iBio shares in Q2 2017, an estimated $29.4K.
iBio made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2794 holding.
Virtu KCG Holdings first reported a position in iBio in Q3 2013 and has held it in 11 quarters since.
Virtu KCG Holdings's iBio position peaked at $60K in Q3 2014.
17 funds tracked by Wall St. Rank held iBio as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.